Science 37 Grants Inducement Equity Awards to New Employees

Science 37 Holdings, Inc., a leading Metasite™ company, has announced the granting of inducement equity awards to new employees under its 2022 Employment Inducement Incentive Award Plan. The awards were approved by the company’s Compensation Committee as a material inducement for non-executive employees to join Science 37.

On October 6, 2023, options to purchase a total of 15,300 shares of Science 37 common stock were granted to three new employees. The exercise price for these options is set at $0.4085 per share, which reflects the closing sales price of Science 37’s common stock on the Nasdaq Stock Market LLC on the grant date. The options have a 10-year term and a four-year vesting schedule, with 25% of the shares vesting on the first anniversary of the grant date and the remaining shares vesting in equal monthly installments until fully vested on the fourth anniversary, subject to continued service with Science 37.

Science 37 Holdings, Inc. is dedicated to accelerating clinical research by providing universal trial access for patients through its innovative Metasite™ platform. This approach expands the reach of clinical trials beyond traditional sites, allowing patients to participate from the comfort of their own homes, local community providers, or traditional sites when necessary. The company’s proprietary technology platform, combined with in-house medical and operational expertise, ensures uniform study orchestration, compliance, and high-quality data.

For more information about Science 37 and its mission to revolutionize clinical research, visit www.science37.com or contact science37@science37.com.

Please note that this press release contains forward-looking statements, and readers are advised to refer to the full release for a comprehensive understanding of the associated risks and uncertainties.